Tarec K. Elajami

Specialized proresolving lipid mediators in patients with coronary artery disease and their potential for clot remodeling

Tarec K. Elajami, Romain A. Colas, Jesmond Dalli et al. · The FASEB Journal · 2016 · 145 citations

Life Sciences, Cardiology, Pharmacology +15

Effect of soy nuts and equol status on blood pressure, lipids and inflammation in postmenopausal women stratified by metabolic syndrome status

Subroto Acharjee, Jin‐Rong Zhou, Tarec K. Elajami et al. · Metabolism · 2014 · 96 citations · Full text

Medicine, Endocrinology, Nutritional Sciences +13

Effect of Eicosapentaenoic and Docosahexaenoic Acids Added to Statin Therapy on Coronary Artery Plaque in Patients With Coronary Artery Disease: A Randomized Clinical Trial

Abdulhamied Alfaddagh, Tarec K. Elajami, Hasan Ashfaque et al. · Journal of the American Heart Association · 2017 · 92 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Regression of human coronary artery plaque is associated with a high ratio of (18‐hydroxy‐eicosapentaenoic acid + resolvin E1) to leukotriene B ₄

Francine K. Welty, Fabian Schulte, Abdulhamied Alfaddagh et al. · The FASEB Journal · 2021 · 54 citations · Full text

Veterinary Medicine, Cardiology, Nutritional Sciences +17

Eicosapentaenoic and Docosahexaenoic Acids Attenuate Progression of Albuminuria in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease

Tarec K. Elajami, Abdulhamied Alfaddagh, Dharshan Lakshminarayan et al. · Journal of the American Heart Association · 2017 · 49 citations · Full text

Medicine, Nutritional Sciences, Pharmacology +11